Helix BioMedix, Inc. (HXBM) Research

Helix BioMedix, Inc. is a U.S.-based enterprise specializing in skin health, focusing on advanced dermatology and consumer-oriented product lines. The company's primary activity involves creating and bringing to market bioactive peptides. These compounds are engineered to combat infections, fungal growths, and inflammation, serving to treat various skin and wound ailments, as well as to deter Staphylococcus aureus infections. Furthermore, Helix BioMedix grants licenses for its distinct peptide technologies to other businesses and entities. Established in 1988, the firm's corporate headquarters are located in Bothell, Washington.

Market snapshot

Symbol
HXBM
Price
$1.79
Day change
0.00%
Market cap
$402.2K
P/E ratio
-0.73x
52-week range
1-6.45
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Bio-Path Holdings, Inc. (BPTH)
  • CENTR Brands Corp. (CNTRF)
  • Emmaus Life Sciences, Inc. (EMMA)
  • Next Generation Management Corp. (NGMC)
  • NovelStem International Corp. (NSTM)
  • Neutra Corp. (NTRR)
  • Orgenesis Inc. (ORGS)
  • Paion AG (PAIOF)

Recent insider activity

  • BEATTY R STEPHEN — P-Purchase (60000 shares) on 2003-12-26
  • BEATTY R STEPHEN — J-Other (25000 shares) on 2003-12-26
  • BEATTY R STEPHEN — X-InTheMoney (60000 shares) on 2003-12-26
  • BEATTY R STEPHEN — J-Other (25000 shares) on 2003-12-26

Open Helix BioMedix, Inc. (HXBM) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.